Electra Therapeutics initiated with overweight rating by J.P. Morgan; price target $36
ETRA•J.P. Morgan initiated coverage of Electra Therapeutics with an overweight rating and a $36 price target.
ETRA•ETRA•ETRA•J.P. Morgan initiated coverage of Electra Therapeutics with an overweight rating and a $36 price target.
